Show notes
Justin, Jen, and Heaton unpack the revised U.S.–Nippon Steel deal, which walks back a full foreign buyout in favor of a limited partnership aimed at easing national security and labor concerns. The crew also dives into the FDA’s shift toward a more targeted COVID booster policy, based on individual risk and prior infection. It's a move that has drawn both praise for scientific rigor and criticism for potentially weakening public trust, and it remains to be seen whether these compromises are strategic or shortsighted.Chapters:00:00:00 - Intro00:07:37 - US-Nippon Steel Deal00:28:15 - COVID Booster Recommendations00:59:04 - Emails01:18:16 - Wrap-up Hosted on Acast. See acast.com/privacy for more information.